Technical Analysis for CDXC - ChromaDex Corporation

Grade Last Price % Change Price Change
grade D 3.83 10.06% 0.35
CDXC closed up 5.14 percent on Tuesday, November 19, 2019, on 1.44 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical CDXC trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 10.06%
Stochastic Reached Overbought Strength 10.06%
Above Upper BB Strength 10.06%
Overbought Stochastic Strength 10.06%
Up 3 Days in a Row Strength 10.06%
Up 4 Days in a Row Strength 10.06%
Up 5 Days in a Row Strength 10.06%
Upper Bollinger Band Touch Strength 10.06%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 15.71%
Pocket Pivot Bullish Swing Setup 15.71%

Older signals for CDXC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
ChromaDex Corporation, a natural products company, through its subsidiaries, discovers, acquires, develops, and commercializes patented and proprietary ingredient technologies. The company supplies bulk raw materials for use in dietary supplements, food, beverages, and cosmetic products; reference standards, materials, and kits to conduct quality control of raw materials and consumer products; and fine chemicals and phytochemicals for research and new product development applications. It also provides a range of contract services, including routine contract analysis for the production of dietary supplements, cosmetics, foods, and other natural products, as well as elaborate contract research for clients in these industries; and consulting services in the areas of regulatory support, new ingredient or product development, risk management, and litigation support, as well as product regulatory approval and scientific advisory services. The company's products and services in development include Nicotinamide riboside, a vitamin found naturally in milk for enhancing cardiovascular health, glucose levels, cognitive function, and anti-aging effects; Pterostilbene and caffeine co-crystal that are ingredients for the formulation of energy products; and Anthocyanins for application in dietary supplement, sports nutrition, food and beverage, and skin care products. In addition, it is developing quality verification seal program, phytochemical libraries, plant extracts libraries, and databases for cross-referencing phytochemicals. The company markets and sells its products directly in the United States and Canada; and through distributors in Europe, South America, China, Korea, India, Japan, Australia, New Zealand, Indonesia, Malaysia, Singapore, Thailand, and Mexico. ChromaDex Corporation is headquartered in Irvine, California.
Chemistry Health Food Chemicals Beverage Consumer Products Risk Management Nutrition Dietary Supplements Dietary Supplement Energy Products Skin Care Products Contract Services Natural Products Cosmetic Products
Is CDXC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 4.95
52 Week Low 2.68
Average Volume 260,050
200-Day Moving Average 3.9788
50-Day Moving Average 3.4714
20-Day Moving Average 3.039
10-Day Moving Average 3.052
Average True Range 0.2248
ADX 27.3
+DI 26.3961
-DI 17.2624
Chandelier Exit (Long, 3 ATRs ) 3.0456
Chandelier Exit (Short, 3 ATRs ) 3.3544
Upper Bollinger Band 3.3999
Lower Bollinger Band 2.6781
Percent B (%b) 1.11
BandWidth 23.751234
MACD Line -0.0538
MACD Signal Line -0.1392
MACD Histogram 0.0855
Fundamentals Value
Market Cap 160.4 Million
Num Shares 46.1 Million
EPS -0.20
Price-to-Earnings (P/E) Ratio -17.40
Price-to-Sales 8.95
Price-to-Book 7.02
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.85
Resistance 3 (R3) 3.83 3.67 3.79
Resistance 2 (R2) 3.67 3.58 3.69 3.77
Resistance 1 (R1) 3.58 3.52 3.62 3.60 3.75
Pivot Point 3.42 3.42 3.45 3.44 3.42
Support 1 (S1) 3.33 3.33 3.38 3.36 3.21
Support 2 (S2) 3.17 3.27 3.19 3.19
Support 3 (S3) 3.08 3.17 3.17
Support 4 (S4) 3.11